F S Guimarães Selected Research

Nitroarginine (NG Nitro L Arginine)

3/2010	Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery.
3/2005	Role of nitric oxide on motor behavior.
4/2002	Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice.
1/2000	Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F S Guimarães Research Topics

Disease

5	Catalepsy 03/2010 - 01/2000
4	Schizophrenia (Dementia Praecox) 01/2018 - 04/2006
4	Panic Disorder (Panic Attack) 08/2014 - 02/2001
2	Mental Disorders (Mental Disorder) 01/2018 - 01/2017
2	Anxiety Disorders (Anxiety Disorder) 04/2003 - 08/2001
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Neurobehavioral Manifestations 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Asthma (Bronchial Asthma) 09/2013
1	Sarcoidosis (Schaumann Disease) 03/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2012
1	Glossophobia 05/2010
1	Hypertrophy 04/2009
1	Mood Disorders (Mood Disorder) 04/2008
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2006
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2000
1	Contusions 05/2000
1	Pain (Aches) 04/2000
1	Parkinsonian Disorders (Parkinsonism) 02/2000

Drug/Important Bio-Agent (IBA)

4	CannabinoidsIBA 01/2017 - 04/2006
4	Nitroarginine (NG Nitro L Arginine)IBA 03/2010 - 01/2000
3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 01/2000
3	Haloperidol (Haldol)FDA LinkGeneric 03/2005 - 01/2000
2	Clostridium perfringens epsilon-toxinIBA 01/2018 - 03/2012
2	EndocannabinoidsIBA 01/2017 - 08/2015
2	RitanserinIBA 05/2010 - 03/2005
2	Serotonin (5 Hydroxytryptamine)IBA 05/2010 - 08/2001
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2010 - 01/2000
2	Arginine (L-Arginine)FDA Link 04/2006 - 03/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2006 - 01/2000
2	Anti-Anxiety Agents (Anxiolytics)IBA 04/2003 - 04/2000
2	Pharmaceutical PreparationsIBA 04/2002 - 02/2001
1	NitrogenIBA 01/2018
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	CytokinesIBA 01/2018
1	Carbon MonoxideIBA 09/2013
1	Escitalopram FDA Link 05/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2010
1	NitritesIBA 03/2010
1	NitratesIBA 03/2010
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2009
1	N-Methylaspartate (NMDA)IBA 04/2008
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 04/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2008
1	Antidepressive Agents (Antidepressants)IBA 04/2008
1	Clozapine (Clozaril)FDA LinkGeneric 04/2006
1	Dopamine (Intropin)FDA LinkGeneric 04/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2006
1	KetanserinIBA 03/2005
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 03/2005
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2005
1	WAY 100135IBA 03/2005
1	7-nitroindazoleIBA 03/2005
1	5-HT1A Serotonin ReceptorIBA 03/2005
1	Atropine FDA LinkGeneric 03/2005
1	Biperiden (Akineton)FDA Link 03/2005
1	Muscarinic AntagonistsIBA 03/2005
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2005
1	Diazepam (Valium)FDA LinkGeneric 11/2004
1	Dimenhydrinate (DMH)FDA LinkGeneric 11/2004
1	BenzodiazepinesIBA 04/2003
1	Urethane (Ethyl Carbamate)IBA 05/2000
1	Proteins (Proteins, Gene)FDA Link 05/2000
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2000
1	Opioid Analgesics (Opioids)IBA 04/2000
1	Cholinergic Agents (Cholinergics)IBA 04/2000
1	ManganeseIBA 02/2000
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2000
1	NADPH Dehydrogenase (Dehydrogenase, NADP)IBA 01/2000

Therapy/Procedure

1	Radiotherapy 07/2015